相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Association Between Cardiac Injury and Mortality in Hospitalized Patients Infected With Avian Influenza A (H7N9) Virus
Chang Gao et al.
CRITICAL CARE MEDICINE (2020)
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
Qiurong Ruan et al.
INTENSIVE CARE MEDICINE (2020)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Preparation for Possible Sustained Transmission of 2019 Novel Coronavirus: Lessons From Previous Epidemics
David L. Swerdlow et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
COVID-19 and the cardiovascular system
Ying-Ying Zheng et al.
NATURE REVIEWS CARDIOLOGY (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Chuan Qin et al.
CLINICAL INFECTIOUS DISEASES (2020)
Transmission potential and severity of COVID-19 in South Korea
Eunha Shim et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy
Graziano Onder et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis
Alfonso J. Rodriguez-Morales et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
Tao Chen et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Early dynamics of transmission and control of COVID-19: a mathematical modelling study
Adam J. Kucharski et al.
LANCET INFECTIOUS DISEASES (2020)
Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
Tao Guo et al.
JAMA CARDIOLOGY (2020)
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China
Shaobo Shi et al.
JAMA CARDIOLOGY (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Clinical Characteristics of Covid-19 in New York City
Parag Goyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Compassionate Use of Remdesivir for Patients with Severe Covid-19
J. Grein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19 A Randomized Clinical Trial
Ling Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019 The GRECCO-19 Randomized Clinical Trial
Spyridon G. Deftereos et al.
JAMA NETWORK OPEN (2020)
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
Giulio Cavalli et al.
LANCET RHEUMATOLOGY (2020)
Prognostic value of NT-proBNP in patients with severe COVID-19
Lei Gao et al.
RESPIRATORY RESEARCH (2020)
Canakinumab in a subgroup of patients with COVID-19
Claudio Ucciferri et al.
LANCET RHEUMATOLOGY (2020)
SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes
Chong-Shan Shi et al.
CELL DEATH DISCOVERY (2019)
Fourth Universal Definition of Myocardial Infarction (2018)
Kristian Thygesen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Multicenter Evaluation of a 0-Hour/1-Hour Algorithm in the Diagnosis of Myocardial Infarction With High-Sensitivity Cardiac Troponin T
Christian Mueller et al.
ANNALS OF EMERGENCY MEDICINE (2016)
From C-Reactive Protein to Interleukin-6 to Interleukin-1 Moving Upstream To Identify Novel Targets for Atheroprotection
Paul M. Ridker
CIRCULATION RESEARCH (2016)
Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial
Bita Shakoory et al.
CRITICAL CARE MEDICINE (2016)
Pharmacokinetic and Pharmacodynamic Properties of Canakinumab, a Human Anti-Interleukin-1β Monoclonal Antibody
Abhijit Chakraborty et al.
CLINICAL PHARMACOKINETICS (2012)
Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes
Jasmin B. Kuemmerle-Deschner et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
Helen J. Lachmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
ACE2: from vasopeptidase to SARS virus receptor
AJ Turner et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Inflammation and atherosclerosis
P Libby et al.
CIRCULATION (2002)